Skip to main content
Premium Trial:

Request an Annual Quote

Formation of Enlight Biosciences Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, July 11.
 
1. Merck, Pfizer, Lilly Form New Company to Speed Development of Drug-Discovery Tools (from July 10)
 
2. Newly Split Celera and ABI Settle on Terms for Sharing Tech and IP, Divvy Up Dx Market (from July 8)
 
3. BD Gets CE Mark for C. difficile Molecular Test (from July 7)
 
4. SACGHS Task Force Sees Consumer Genomics as 'Number One Priority' (from July
7)
 
5. NIH, Sanger Researchers Develop Assay for Assessing BRCA2 Variants (from July 8)
The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.